MB Financial Inc. stock price, MBFI

MB Financial Inc. stock chart:



MB Financial Inc. close price: 41.35

Stock price forecast:

UP TO +2.47%
Target: 42.37

Total forecasts: 82
Reached: 41 (50.00%)

Total Win: 25.22 (55.56%)

DaysForecastsReached%Reached points%InvestedUnreached%Total%
90834250.60%26.790.71%1,738.19-42.84-2.46%-16.05-0.44%
302300.00%0.000.00%940.6310.421.11%10.421.11%
141500.00%0.000.00%607.5012.752.10%12.752.10%
7800.00%0.000.00%323.297.512.32%7.512.32%

Showing 1-10 of 537 items.
Date of ForecastStock PriceTarget PriceForecast Reached Date
2017-04-2341.3542.380000-00-00
2017-04-2241.3542.410000-00-00
2017-04-2141.1642.280000-00-00
2017-04-2040.2441.770000-00-00
2017-04-1939.9941.850000-00-00
2017-04-1840.18420000-00-00
2017-04-1739.5141.60000-00-00
2017-04-1639.5141.670000-00-00
2017-04-1539.5141.720000-00-00
2017-04-1439.5142.520000-00-00

MB Financial Inc. latest news:


  • 04/19/2017 14:03:02

    Pfizer is latest to get Justice Department subpoena in intravenous saline investigation

    Pfizer Inc. has been subpoenaed by the Justice Department as part of an antitrust investigation into intravenous saline sales practices, requests that it is "evaluating," the company said Wednesday. Saline is a salt water solution that's widely used in the medical system. The shortage caught attention in recent years, with manufacturers claiming they just couldn't keep up with demand. Prices rose 200% to 300% since the 2013 shortage, according to a letter sent by four senators to the Federal Trade Commission in late October 2015. Pfizer acquired Hospira, one of three main saline manufacturers, in September 2015. Wednesday's news follows a Tuesday disclosure by ICU Medical , which Pfizer completed a sale of its infusion therapy assets to in early February, that it had been subpoenaed in connection with an investigation. ICU Medical said it has also had a request from the New York Attorney General for information on its IV solution sales practices, and that "both of these investigations relate primarily to time periods prior to the Company's ownership." The subpoena called for "documents regarding the manufacturing, selling, pricing and shortages of intravenous ("IV") solutions, including saline, sold by the Company and communications with competitors regarding the same," ICU Medical said. Pfizer said in a March 16 financial filing that it was being sued in an Illinois district court for allegedly artificially raising prices of IV saline solution, with the lawsuit aiming for class action status. On Friday, another company, Baxter International Inc. , said that one of its employees had received agrand jury subpoena as part of an investigation into its saline sales practices. Pfizer shares slumped 0.6% in Wednesday afternoon trade. Shares have risen 6.2% over the last three months, compared with a 3.3% rise in the S&P 500 . Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 04/18/2017 09:32:51

    Goldman's stock suffering biggest post-earnings drop in over six years

    It's not surprise that Goldman Sachs Group Inc.'s stock is declining in the wake of first-quarter results reported before the open, but how much it's falling may shock for investors. The banker's stock slumped 4.2% in morning trade to $216.78 after both profit and sales missed expectations. That would be the biggest one-day, post-earnings percentage decline since it fell 4.7% on Jan. 19, 2011 after Goldman reported fourth-quarter 2010 results. On the day following the previous 25 quarterly reports since then, the stock has fallen after 16 of them, by an average of 1.5%, according to an analysis of FactSet data. On the days after quarterly reports that the stock rose, the average gain was 2.8%. Analyst Steven Chuback at Instinet said Tuesday's report offers Goldman bears "quite a bit of fodder" given the significantly weaker trading results than its peers. He reiterated his neutral rating and $220 stock price target, which is just 0.8% above current levels. The stock has tumbled 9.3% year to date, while the SPDR Financial Select Sector ETF has eased 0.6% and the Dow Jones Industrial Average has gained 4%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 04/18/2017 09:05:51

    UPDATE 1-Bank of America's wealth revenue surges on assets under management, fees

    NEW YORK, April 18 (Reuters) - Bank of America's wealth business reported revenue climbed 3 percent to $4.6 billion in the first quarter this year from last year on higher client assets under management and fees, Bank of America Chief Financial Officer Paul Donofrio said Tuesday.

  • 04/18/2017 07:24:21

    Vera Bradley signs agreement to design clothes, accessories for health care professionals

    Vera Bradley Inc. said Tuesday it signed a licensing agreement with CID Resources Inc. to design apparel and accessories for female health care professionals. This is a new product category for the company, according to a statement from Chief Executive Rob Wallstrom, with the medical uniforms market estimated at $1.8 billion in the U.S. Nearly 20% of Vera Bradley's customers say they work in the health care industry, he said. The line, which will include uniforms, tote bags and ID badge holders, is expected to launch in spring 2018. Since September 2016, Vera Bradley has entered into licensing agreements with companies such as Peking Handicraft Inc. for bedding, rugs and kitchen textiles, and Mainstream Swimsuits Inc. for swimwear and cover-ups. Licensing partnerships are not expected to have a material impact on financial performance for the fiscal year ending Feb. 3, 2018. Vera Bradley shares are inactive in premarket trading, and down nearly 49% for the past year. The S&P 500 index is up 12.2% for the last 12 months.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 04/17/2017 14:04:30

    Stock market halts 3-session skid with largest gain since March 1

    U.S. stocks rebounded on Monday, notching their largest gains since March 1, as financial shares led markets higher while investors monitored corporate earnings and the latest developments between the U.S. and its geopolitical adversaries. The S&P 500 index climbed 20.06 points, or 0.9%, to 2,349.01, while the Dow Jones Industrial Average rose 183.67 points, or 0.9%, to 20,636.92. The Nasdaq Composite Index gained 51.64 points, or 0.9%, to 5,856.79. Shares of United Continental Holdings Inc. [S: UAL] and Netflix Inc. rose as both firms prepared to report quarterly earnings after the bell. United shares tumbled last week as the company took heat after video surfaced of a customer being violently dragged off a plane. The company is now facing a lawsuit filed by the passenger. Shares of MoneyGram International Inc. climbed after Alibaba Group Holding Ltd controlled Ant Financial Services lifted its bid for the U.S. money-transfer unit. Bank of America Inc. shares will be in focus as the company prepares to report quarterly earnings on Tuesday before the bell. In other markets, gold futures settled higher on Monday for a fourth straight session. One ounce of gold for June delivery rose $3.40, or 0.3%, to $1,291.90.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 04/13/2017 14:17:29

    BRIEF-Trimble announces new reporting segments

    * Trimble Inc - will change reporting of its segment financial results

  • 04/12/2017 18:03:32

    Yext IPO prices at $11, stock set to trade Thursday

    Yext Inc. priced its initial public offering at $11 a share Wednesday, $1 higher than its projected range, pulling in at least $115.5 million at a valuation of $940 million as enterprise-software offerings continued to succeed on Wall Street. The New York tech startup, which helps businesses ensure the accuracy of locations and other data across digital platforms, is expected to begin trading Thursday morning on the New York Stock Exchange under the ticker symbol YEXT. Founded in 2006, Yext disclosed in IPO filings that it had a net loss of $43.2 million on revenue of $124.3 million in its most recent fiscal year, which ended Jan. 31. Both sales and losses increased from the prior year, when the company reported a net loss of $26.5 million on revenue of $89.7 million. Yext raised more than $117 million in private investment, according to Crunchbase, and the IPO prospectus showed shares selling for $5.81 in its most recent round of venture funding, in 2014. Four venture-capital firms -- Sutter Hill Ventures, Institutional Venture Partners, Marker Financial Advisors and Insight Venture Partners -- held more than 10% of the company ahead of the IPO, with Sutter Hill leading the way with 23.6% of the company. No investors are selling shares in the IPO; Yext will take all of the proceeds on the sale of 10.5 million shares, and underwriting banks have access to an additional 1.6 million shares that they could potentially sell. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 04/12/2017 15:02:49

    Financials turn negative for the year ahead of key bank earnings

    The S&P financial sector fell on Wednesday and turned negative for the year, in the latest indication that one of the strongest trades of the postelection rally is unraveling. The sector lost 0.9% on Wednesday, while the Financial Select Sector SPDR ETF , the largest exchange-traded fund to specifically track financials, lost 0.8%. With the day's move, financials are now down 0.3% for the year. The banking sector had been one of Wall Street's most profitable trades in the aftermath of President Donald Trump's November election win. At one point, financials accounted for more than half the overall stock market's advance. However, it has fallen more than 8% since early March, leading the overall market lower. Losses have come amid broad concerns about valuation, as well as the Federal Reserve indicating it might only raise interest rates by three times in 2017. Bank profits tend to be stronger in periods of higher rates, and investors had previously expected as many as four hikes this year. Despite expectations for higher rates going forward, benchmark bond yields have been trading at multi-month lows. The 10-year Treasury yielded 2.24% late Wednesday, near a five-month low. Caution over the financial sector has also been elevated going into the first-quarter earnings season, with investors looking for confirmation that its valuations are justified. A number of key banks will be reporting quarterly results in the coming days, including J.P. Morgan Chase & Co. , Citigroup Inc. and Wells Fargo & Co. on Thursday. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 04/03/2017 11:04:51

    Mylan's EpiPen recall likely to have low U.S. revenue impact: EvercoreISI analyst

    Mylan NV's EpiPen recall, which the company said late last week would extend to the U.S., will likely have a low impact on the company's revenue, Evercore ISI analyst Umer Raffat said Monday. The main cost to Mylan will be replacing the recalled EpiPens, all of which are expiring in the next several months, and thus delaying the purchase of new EpiPens for affected patients by about a year, Raffat said. He estimated the cost at about 3%, or $21 million of Mylan's expected $650 million in U.S. EpiPen sales this year. The EpiPen recall, which Mylan had previously said was confined to about 81,000 EpiPens distributed in Australia, New Zealand, Europe and Japan, was expanded to the U.S. on Friday as a "precautionary measure," since there is the possibility the products have a defective part and might not work in an emergency situation, Mylan said. The U.S. recall applies to 13 lots distributed between December 2015 and July 2016, which Raffat estimated at about 260,000 devices. The products affected by the recall are expected to expire in April, September and October of this year. The recall was prompted by reports of two EpiPens outside of the U.S. failing to activate, and the single lot they were from has already been recalled, Mylan said. Raffat said that it's "comforting to know that this additional recall is more precautionary rather than on the heels of additional malfunction cases." Mylan hasn't filed any financial disclosures about how the recall will affect its business but, according to Bernstein analyst Ronny Gal, "Mylan is doing the math and will consider putting out some disclosure on financial implications." Mylan shares declined 8.6% over the last three months, compared with a 4.2% rise in the S&P 500 . Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 03/31/2017 20:50:00

    Disclosures Outline The Wealth Of The Trump Administration

    As members of Trump's staff disclosed their financial assets, new details have emerged about the wealth of Ivanka Trump, Jared Kusher, Steve Bannon, Gary Cohn and former adviser Michael Flynn.

  • 03/15/2017 11:52:12

    BRIEF-Fronsac REIT says Jason Parravano appointed CEO, president

    * Jacques Beaudry, a member of board of trustees, will assume role of interim chief financial officer

  • 03/02/2017 14:28:27

    Nutanix plunges after disappointing forecast

    Nutanix Inc. , one of the hottest tech IPOs of 2016, plunged more than 17% Thursday after its second earnings report as a public company issued a forecast that didn't meet Wall Street's expectations. The company, which sells cloud computing resources focused on combining storage and computing power, reported a net loss of $93.2 million, or 66 cents a share, on sales of $182.2 million. After adjusting for stock-based compensation, the company claimed a loss of 28 cents a share. That performance in the company's second fiscal quarter easily beat analysts' estimates of adjusted losses of 35 cents a share on sales of $178.4 million, according to FactSet. Nutanix's forecast for the current quarter did not meet expectations, however. The company said it expects adjusted losses of 45 cents to 48 cents a share in the fiscal third quarter on revenue of $180 million to $190 million. Analysts on average projected adjusted losses of 35 cents a share on sales of $188.5 million, FactSet reported. Nutanix Chief Financial Officer Duston Williams noted in the announcement that increased costs of some components were affecting the company's costs; Hewlett Packard Enterprise Co. said in its earnings call last week that increased prices for some memory chips had affected its results. Nutanix, which also suffered after its first earnings report as a public company, fell lower than $26 in late trading after closing with a 1.3% gain at $31.12.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 02/21/2017 16:27:58

    Aeromexico board supports Delta's offer of increased stake

    Grupo Aeromexico SAB de CV said its board would accept Delta Air Lines Inc.'s offer to acquire a 49% stake in the company. Back in November, Delta offered to increase its interest in the Mexican airline from its current 4.3% stake for 43.59 pesos a share, and on Feb. 13 boosted that offer to 53 pesos a share because of a decline in the peso. Since November, Aeromexico shares have risen 25% in local currency and last closed at 46.93 pesos a share. Aeromexico, in a statement, said its board "considers such price is both supported from a financial perspective and represents fair value." Delta shares declined 0.1% to $51.15 after hours.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 02/21/2017 14:10:45

    Fed's Williams touts potential benefits of blockchain technology

    San Francisco Federal Reserve President John Williams said Tuesday that blockchain technology could lower costs while making record keeping easier and more efficient. Williams, who was speaking at Boise State University, also said that people increasingly understand that bitcoin won't replace government-issued currencies like the U.S. dollar. Back in December, the Fed published a paper examining how blockchain technology could be applied in the financial industry. Fed Chairwoman Janet Yellen has previously said that blockchain technology could have a significant impact on the payments system.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 02/21/2017 11:37:47

    Wells Fargo fires 4 managers as part of investigation into sales scandal

    Wells Fargo & Co. said Tuesday it terminated "for cause" four current or former senior managers in its community banking business following an ongoing investigation into the banking giant's sales practice scandal. The terminated managers are Claudia Russ Anderson, the former chief risk officer for the community bank; Pamela Conboy, lead regional president of Arizona; Shelley Freeman, the former Los Angeles regional president, and currently the head of consumer credit solutions; and Matthew Raphaelson, head of Community Bank strategy and initiatives. Wells Fargo said its investigation is expected to be completed before the shareholder meeting in April 2017. Wells Fargo was embroiled in a scandal last year, which led to the resignation of former Chief Executive John Stumpf, in which millions of credit-card and deposit accounts were opened without customers' knowledge in an effort to meet sales targets. The bank's stock, which slipped 0.2% in afternoon trade, has gained 21% over the past 12 months, while the SPDR Financial Select Sector ETF has run up 44% and the S&P 500 has climbed 23%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 02/16/2017 17:09:30

    REFILE-Father, son in Gerova stock scam get six years prison

    Feb 16 (Reuters) - Two members of a family conspiracy to manipulate the stock of reinsurer Gerova Financial Group Ltd were sentenced to six years in prison on Thursday, a day after the scheme's main architect received a more than 11-year term, prosecutors said.

  • 02/16/2017 16:03:12

    Father, son in Gerova stock scam get six years prison

    Feb 16 (Reuters) - Two members of a family conspiracy to manipulate the stock of reinsurer Gerova Financial Group Ltd were sentenced to six years in prison on Thursday, a day after the scheme's main architect received a more than 11-year term, prosecutors said.

  • 02/16/2017 09:18:04

    Senate confirms Mulvaney, Trump choice OMB director

    WASHINGTON (MarketWatch) - The Senate confirmed Mick Mulvaney as President Donald Trump's choice to run the Office of Management and Budget in a narrow 51-49 vote. Sen. John McCain was the lone Republican to vote against Mulvaney owing to efforts by the former congressman to cut military spending and pare down the deficit. The OMB director plays a big role in advising the White House on spending and other financial matters. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 02/13/2017 13:37:25

    BRIEF-Fishing League Worldwide extends Procter & Gamble sponsorship to continue featuring Old Spice brand in 2017

    * Fishing League Worldwide extends sponsorship with Procter & Gamble to continue featuring Old Spice brand in 2017; financial terms of extension not available Source text for Eikon: Further company coverage:

  • 02/06/2017 17:14:49

    EBay finds 'material weakness' in controls over accounting for tax

    EBay Inc said on Monday it had found that it improperly accounted for tax on certain transactions completed in December, which constituted a material weakness in its internal control over financial reporting.

  • 02/03/2017 14:37:46

    Banks, jobs data send Wall Street higher

    NEW YORK (Reuters) - U.S. stocks climbed on Friday, with the S&P 500 closing just short of a record high, boosted by gains in financial shares as President Donald Trump moved ahead with deregulation action and by a strong payrolls report.

  • 02/03/2017 14:04:53

    Wall Street gains as financials surge

    NEW YORK (Reuters) - U.S. stocks climbed on Friday, with the S&P 500 closing just short of a record high, boosted by gains in financial shares as President Donald Trump moved ahead with deregulation action and by a strong payrolls report.

  • 02/03/2017 08:00:21

    Goldman adds 50 points to Dow amid deregulation talk

    Goldman Sachs on Friday was contributing the lion's share of the Dow Jones Industrial Average's rally in early trade. Goldman Sachs Group's shares were climbing 3.2%, to add about 50 points to the Dow , representing the biggest contributor to the price-weighted blue-chip gauge, which was up about 108 points, or 0.6%, higher at 19,992. Goldman's rally comes as President Donald Trump's administration begins a rethink of the way big American financial firms are regulated, with a focus on repealing many of the Dodd-Frank bank reform rules implemented in the wake of the 2008-09 financial crisis. Critics say the rule hampers banks' ability to be competitive in international markets. A pledge to roll back regulations had been among the centerpieces of Trump's presidential campaign platform. Gary Cohn, director of the White House National Economic Council and former president of Goldman, told The Wall Street Journal Thursday that the administration would review some of the main mechanisms that have shaped how financial firms have been governed. Goldman's gain comes amid a broad rally for the banking sector and comes even as yields of benchmark 10-year Treasury bonds declined in the wake of a jobs report that showed that wage growth, a negative for bonds, is rising only modestly. Tepid inflation can be supportive for bonds because rising inflation erodes their fixed payments. But lower rates can undercut a bank's business model. Investors are betting that deregulation will be a bigger driver for bank's future profits.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 02/01/2017 15:31:15

    JPMorgan to pay Lehman $797.5 million to end litigation over collapse

    NEW YORK (Reuters) - JPMorgan Chase & Co will pay $797.5 million in cash to end all litigation brought on behalf the former Lehman Brothers Holdings Inc, whose September 2008 collapse triggered a global financial crisis.

  • 01/23/2017 06:21:06

    NCI finds controller stole $18 million from the company over six years

    Shares of NCI, Inc. fell 13% in premarket trade Monday after the company said its controller had embezzled $18 million from the company over six years. NCI, a provider of information technology and professional services for U.S. government agencies, said it had fired the controller and has begun an internal investigation into the issue. The company believes it will be able to recover a large portion of the stolen money. NCI said it believes the controller was acting alone and had taken about $5 million in 2016 and $13 million over the prior five years. The company said this money showed up as expenses in NCI's financial statements and that the unadited financial statements in the company's form 10-Q's for the first three quarters of 2016 cannot be relied on. NCI is working with legal counsel and federal authorities on the matter. Shares of NCI have gained 21% in the past three months, compared to the S&P 500's gain of 6%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • More trends:

    MB Financial Inc.MBFIP | MCBC Holdings, Inc.MCFT | McGrath RentCorpMGRC | MDC Partners Inc.MDCA | Mecox Lane LimitedMCOX | Medallion Financial Corp.TAXI | MedAssets, Inc.MDAS | Medical Transcription Billing, Corp.MTBC | MediciNova, Inc.MNOV | Medidata Solutions, Inc.MDSO |